Impact of a metabolic screening bundle on rates of screening for metabolic syndrome in a psychiatry resident outpatient clinic

被引:11
作者
Ilse R. Wiechers
Mark Viron
Joseph Stoklosa
Oliver Freudenreich
David C. Henderson
Anthony Weiss
机构
[1] Dept. of Psychiatry, Massachusetts General Hospital, Boston, MA
[2] Dept. of Psychiatry, Yale School of Medicine, VA Connecticut Healthcare System
关键词
Antipsychotic Medication; Academic Psychiatry; Psychiatry Resident; Quality Improvement Intervention; Metabolic Screening;
D O I
10.1176/appi.ap.10090138
中图分类号
学科分类号
摘要
Objective: Although it is widely acknowledged that secondgeneration antipsychotics are associated with cardiometabolic side effects, rates of metabolic screening have remained low. The authors created a quality-improvement (QI) intervention in an academic medical center outpatient psychiatry resident clinic with the aim of improving rates of screening for metabolic syndrome in patients being prescribed antipsychotic medications. Methods: The core components of the QI intervention included resident education and creation of a metabolic screening bundle for the electronic medical record. Quarterly audits of individual patient electronic medical records assessed whether a patient was currently prescribed antipsychotics and whether metabolicsyndrome screening had been documented at any time in the preceding 12 months. Results: In each audit period, from 131 to 156 patients (30%- 36% of total clinic sample) were prescribed antipsychotic medication. After the intervention, rates of documentation of the components of the metabolic screening bundle increased between 3.5- and 10-fold (final rates: 39% for blood pressure, 44% for BMI, and 55% for glucose and lipid panel). Rates of documenting the full bundle increased nearly 30-fold (final rate: 31%). Conclusion: Provider-education combined with introduction of a documentation bundle in the electronic medical record increased rates of documented metabolic screening in patients Copyright © 2012 Academic Psychiatry.
引用
收藏
页码:118 / 121
页数:3
相关论文
共 10 条
[1]  
Newcomer J.W., Metabolic considerations in the use of antipsychotic medications: A review of recent evidence, J Clin Psychiatry, 68, SUPPL.1, pp. 20-27, (2007)
[2]  
Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., Lenfant C., Definition of metabolic syndrome: Report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition, Circulation, 109, 3, pp. 433-438, (2004)
[3]  
Consensus development conference on antipsychotic drugs and obesity and diabetes, Diabetes Care, 27, pp. 596-601, (2004)
[4]  
Marder S.R., Essock S.M., Miller A.L., Buchanan R.W., Casey D.E., Davis J.M., Kane J.M., Lieberman J.A., Schooler N.R., Covell N., Stroup S., Weissman E.M., Wirshing D.A., Hall C.S., Pogach L., Pi-Sunyer X., Bigger J.T., Friedman A., Kleinberg D., Yevich S.J., Davis B., Shon S., Physical health monitoring of patients with schizophrenia, American Journal of Psychiatry, 161, 8, pp. 1334-1349, (2004)
[5]  
Goff D.C., Cather C., Evins A.E., Et al., Medical morbidity and mortality in schizophrenia: Guidelines for psychiatrists, J Clin Psychiatry, 66, pp. 183-194, (2005)
[6]  
Buckley P.F., Miller D.D., Singer B., Arena J., Stirewalt E.M., Clinicians' recognition of the metabolic adverse effects of antipsychotic medications, Schizophrenia Research, 79, 2-3, pp. 281-288, (2005)
[7]  
Barnes T.R.E., Paton C., Hancock E., Cavanagh M.-R., Taylor D., Lelliott P., Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: A quality improvement programme, Acta Psychiatrica Scandinavica, 118, 1, pp. 26-33, (2008)
[8]  
Mackin P., Bishop D.R., Watkinson H.M.O., Et al., A prospective study of monitoring practices for metabolic disease in antipsychotic- treated community psychiatry patients, BMC Psychiatry, 7, (2007)
[9]  
Haupt D.W., Rosenblatt L.C., Kim E., Et al., Prevalence and predictors of lipid and glucose monitoring in commerciallyinsured patients treated with second-generation antipsychotic agents, Am J Psychiatry, 166, pp. 345-353, (2009)
[10]  
Berenholtz S.M., Milanovich S., Faricloth A., Et al., Improving care for the ventilated patient, Jt Comm J Qual Saf., 30, pp. 195-204, (2004)